RareSearch logo

BioLamina

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Meghan Murazik profile

Meghan Murazik

🇲🇽 Mexico

6.2

    Reviewed:

  • - Clinical Protocol Design
  • - 10 weeks January - March 2024
  • - Pharmaceutical Company

Inconsistent quality of deliverables, frequent revisions needed.

The protocol design process required multiple revisions due to inconsistencies in the deliverables. Although the team was responsive to feedback, the back-and-forth extended the timeline beyond what was originally agreed upon.

Dr. Judith Larkin profile

Dr. Judith Larkin

🇯🇵 Japan

9.1

    Reviewed:

  • - Clinical Data Management
  • - 6 weeks June - July 2023
  • - CRO

Timely and accurate data management, great collaboration.

The data management services were delivered on time and with great accuracy. Collaboration with the team was smooth, and they were always available to address any concerns or questions we had. We were very satisfied with the outcome.

Robert Ward profile

Robert Ward

🇮🇹 Italy

8.8

    Reviewed:

  • - Biostatistical Design
  • - 4 weeks May - June 2023
  • - Research Institution

Excellent biostatistical support, clear and actionable insights.

The biostatistical support provided was top-notch, offering clear and actionable insights that were critical to the success of our study. The team was responsive and worked closely with us to ensure the analysis met our specific needs.

Bonnie Kessler profile

Bonnie Kessler

🇸🇦 Saudi Arabia

6

    Reviewed:

  • - Health Technology Assessment
  • - 8 weeks July - September 2024
  • - Pharmaceutical Company

Health technology assessment was superficial, lacked thorough analysis.

The health technology assessment (HTA) was superficial and did not provide the level of thorough analysis we needed. Some important factors were overlooked, and we had to request additional work to cover these gaps. The overall experience was disappointing.

Gustavo Botsford profile

Gustavo Botsford

🇺🇸 United States

9

    Reviewed:

  • - Clinical Protocol Design
  • - 6 weeks April - May 2023
  • - Pharmaceutical Company

Comprehensive protocol design, very detailed and precise.

The protocol design provided was comprehensive and very detailed. It laid a strong foundation for our clinical trial, ensuring that all regulatory and ethical considerations were addressed. The attention to detail was impressive.

Pamela Nolan profile

Pamela Nolan

🇷🇺 Russia

9.3

    Reviewed:

  • - Project Management
  • - 10 weeks July - September 2023
  • - Biotech Company

Seamless project management, results exceeded expectations.

Project management was seamless, and the team exceeded our expectations. They handled all aspects of the project with professionalism and efficiency, keeping us informed every step of the way.

Jonathan Labadie profile

Jonathan Labadie

🇳🇱 Netherlands

9

    Reviewed:

  • - Biomarker Development
  • - 12 weeks October 2023 - January 2024
  • - Research Institution

Efficient and precise biomarker development.

The biomarker development project was managed efficiently, with precise results that met our project objectives. The team's expertise in biomarker research was invaluable, and we were impressed with the quality of the deliverables.

Esther Moore III profile

Esther Moore III

🇳🇱 Netherlands

9.5

    Reviewed:

  • - Gene Therapy Development
  • - 12 weeks January - March 2023
  • - Research Institution

Innovative approach to gene therapy development, collaborative team.

The gene therapy project was managed exceptionally well, with innovative solutions provided at every stage. The team was highly collaborative and receptive to feedback, making it a truly joint effort. The results exceeded expectations.

Lucia Schneider profile

Lucia Schneider

🇦🇺 Australia

5.7

    Reviewed:

  • - Project Management
  • - 12 weeks March - May 2024
  • - Biotech Company

Poor communication and missed deadlines caused frustration.

Communication from the project management team was poor, with frequent missed deadlines. This caused significant frustration on our end, as we had to repeatedly chase them for updates. The project eventually got back on track, but the delays were problematic.